Preclinical

Cell therapy has emerged as a promising approach in the field of cancer treatment, and chimeric antigen receptor (CAR) T-cell therapy has shown extraordinary potential in harnessing the patient’s immune system to combat solid and hematologic tumors. However, before this revolutionary therapy can be applied in the clinical setting, extensive preclinical evaluation is imperative to...

Read more +

The dynamic field of cancer research is continually evolving, driven by the pursuit of deeper understanding and novel therapeutic strategies against...

Read more +

For decades, the foundations of cancer treatment have been surgery, chemotherapy, and radiation therapy. However, these treatments are not always...

Read more +

Recently, there have been published reports stating that a large proportion of studies published in high-impact scientific journals could not be...

Read more +

A sound preclinical plan coupled with expert oncology guidance can help identify biomarkers that can assist with patient selection—or help...

Read more +

Too often, new drugs fail during development due to poor study design and inadequate knowledge about the performance of a new drug. A large part of...

Read more +

View More
Skip to content